$QTTB
Q32 Bio Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Waltham, MA
QTTB chart
What traders are saying about $QTTB
Latest postsQ32 Bio Inc. news
- Vicore Pharma Holding AB (VCRE) Stock Price, Quote, News & History
Benzinga ·
- Q32 Bio Inc. Estimates – NASDAQ:QTTB
TradingView ·
- QTTB Q2 2026 Earnings: Narrower-Than-Expected Loss of $0.43 Per Share Beats Consensus - Consensus Beat Rate
https://www.dars.gov.et/ ·
- This Biotech Had Good News for Hair Loss Sufferers. So Why Is the Stock Sinking?
Yahoo Finance ·
- Q32 Bio Presents Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata in a Late-Breaker at the European Academy of Dermatology and Venereology Congress 2026
Yahoo Finance ·
- Q32 Bio Announces Upcoming Late-Breaking Presentation of Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata at the European Academy of Dermatology and Venereology Congress 2026
Yahoo Finance ·
- Q32 Bio Appoints José Trevejo, M.D., Ph.D., as Chief Medical Officer and Ellie Hershberger, Pharm.D., as Chief Development Officer
Yahoo Finance ·
- Down 23.1% in 4 Weeks, Here's Why Q32 Bio (QTTB) Looks Ripe for a Turnaround
Yahoo Finance ·
- These 2 ‘Monster Growth’ Stocks Aren’t Done Climbing, Say Analysts
Yahoo Finance ·
- Q32 Bio to Participate in Upcoming September Investor Conferences
Yahoo Finance ·
- Wall Street Analysts See an 182.18% Upside in Q32 Bio (QTTB): Can the Stock Really Move This High?
Yahoo Finance ·
- Q32 Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Yahoo Finance ·
Q32 Bio Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $53.7M | $0 | -$6.7M | – |
| Net income | $29.8M | -$47.7M | -$53.7M | -$5.0M |
| Diluted EPS | $2.42 | $-6.58 | $-153.96 | $-0.09 |
| Total assets (year end) | $61.8M | $92.3M | $47.1M | $228.5M |
| Cash and equivalents (year end) | $48.3M | $78.0M | $25.6M | $34.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Q32 Bio Inc.
- Ticker
- QTTB (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Waltham, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1661998
- Former names
- Q32 Bio Inc., Homology Medicines, Inc.
Frequently asked questions
What exchange is Q32 Bio Inc. listed on?
Q32 Bio Inc. trades on the Nasdaq under the ticker symbol QTTB.
What industry is Q32 Bio Inc. in?
Q32 Bio Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Q32 Bio Inc. headquartered?
Q32 Bio Inc.'s business address on file with the SEC is in Waltham, MA.
When does Q32 Bio Inc.'s fiscal year end?
Q32 Bio Inc.'s fiscal year ends on December 31.
How much revenue did Q32 Bio Inc. report?
Q32 Bio Inc. reported $53.7M in revenue for calendar year 2025, according to its SEC filings.